Reconstituted CD74+ NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation

• Published in: Journal of autoimmunity Vol. 147; p. 103274
• Main Authors: Dou, Yingchao, Nian, Zhigang, Wang, Dongyao, Sun, Guangyu, Zhou, Li, Hu, Ziming, Ke, Jieqi, Zhu, Xiaoyu, Sun, Rui, Tian, Zhigang, Fu, Binqing, Zhou, Yonggang, Wei, Haiming
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.07.2024
• Subjects: allo-HSCT; CD74; GVL; NK cells; Pulmonary cGVHD; CD74; NK cells; GVL; Pulmonary cGVHD; allo-HSCT
• ISSN: 0896-8411; 1095-9157; 1095-9157
• DOI: 10.1016/j.jaut.2024.103274

Chronic graft-versus-host disease (cGVHD) is the most common long-term complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The patients with pulmonary cGVHD in particular have a very poor prognosis. NK cells are the first reconstituted lymphocyte subset after allo-HSCT; however, the impact of reconstituted NK cells on cGVHD is unclear. Here, we found allogeneic recipients showed obvious pulmonary cGVHD. Surprisingly, deletion of reconstituted NK cells resulted in maximal relief of pulmonary cGVHD. Mechanistically, reconstituted NK cells with donor profiles modulated the pulmonary inflammatory microenvironment to trigger cGVHD. Reconstituted NK cells secreted IFN-γ and TNF-α to induce CXCL10 production by epithelial cells, which recruited macrophages and CD4+ T cells to the lungs. Then macrophages and CD4+ T cells were activated by the inflammatory microenvironment, thereby mediating lung injury. Through assessment of differences in cellular energy, we found that CD74+ NK cells with high mitochondrial potential and pro-inflammatory activity triggered pulmonary cGVHD. Furthermore, targeted elimination of CD74+ NK cells using the anti-CD74 antibody significantly alleviated pulmonary cGVHD but preserved the CD74− NK cells to exert graft-versus-leukemia (GVL) effects. Data from human samples corroborated our findings in mouse models. Collectively, our results reveal that reconstituted CD74+ NK cells trigger pulmonary cGVHD and suggest that administration of CD74 antibody was a potential therapeutic for patients with cGVHD. •Reconstituted NK cells trigger cGVHD.•Identifying CD74+ NK cells as cGVHD inducers by assessing mitochondrial potential.•Clearance of CD74+ NK cells does not affect the GVL effects.•Identifying CD74 as a potential therapeutic target for cGVHD patients.